Background
Mitsuya was born in Sasebo, Nagasaki and received his Doctor of Medicine
- Photos
- Works
- Photos
- Works
Hiroaki Mitsuya
Edit Profile満屋 裕明
Education
And Doctor of Philosophy from Kumamoto University.
Career
He joined the American National Cancer Institute in Bethesda, Maryland, in 1982, working initially on Human T-lymphotropic virus 1 before switching his attention to Human Immunodeficiency Virus. His identification of AZT as an anti-Human Immunodeficiency Virus drug, as well as the anti-Human Immunodeficiency Virus properties of didanosine and zalcitabine, was made in 1985. He was appointed Professor of Hematology, Rheumatology and Clinical Immunology at Kumamoto University Graduate School of Medical And Pharmaceutical Sciences. In December, 2006, he was awarded the first National Institutes of Health World Acquired Immune Deficiency Syndrome for his work in developing drugs for Acquired Immune Deficiency Syndrome. Mitsuya has been chief of the National Cancer Institute"s Experimental Retrovirology Section since 1991.
